Literature DB >> 3132220

Improved screening for colorectal cancer by immunological detection of occult blood.

D J Frommer1, A Kapparis, M K Brown.   

Abstract

A radial immunodiffusion technique for detecting faecal haemoglobin and the Hemoccult II kit used with and without rehydration of the faecal sample were compared in a screening programme for bowel cancer, in which 1328 subjects took part. A positive result was obtained in 170 (13%) subjects. Nineteen of the 153 subjects investigated were found to have colorectal carcinomas and 52 had polyps (40 with adenomas). Radial immunodiffusion and Hemoccult II with and without rehydration detected bleeding in, respectively, all 19, 15, and 11 subjects with colorectal carcinoma. Hemoccult II with and without rehydration detected only seven and six, respectively, of 11 Duke's stage A carcinomas, whereas all 11 were detected with the immunological test. Hemoccult II with and without rehydration and radial immunodiffusion detected bleeding from adenomas in, respectively, 22, 14, and 34 of the 40 subjects. False positive results occurred in 55 out of 1302 subjects by Hemoccult II with rehydration, in 28 out of 1304 by Hemoccult II without rehydration, and in 50 out of 1304 by the immunological technique; true positive results were defined as bleeding from carcinomas and adenomas. Immunological detection of occult blood in faecal samples seems to show more adenomas and carcinomas (particularly early lesions) than the Hemoccult II kit and has a rate of false positive results that is acceptably low.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132220      PMCID: PMC2545498          DOI: 10.1136/bmj.296.6629.1092

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Value of periodic examinations in detecting cancer of the rectum and colon.

Authors:  R E HERTZ; M R DEDDISH; E DAY
Journal:  Postgrad Med       Date:  1960-03       Impact factor: 3.840

2.  Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer.

Authors:  A Schatzkin; R J Connor; P R Taylor; B Bunnag
Journal:  Am J Epidemiol       Date:  1987-04       Impact factor: 4.897

Review 3.  Towards safer colonoscopy.

Authors:  R H Hunt
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

4.  Optimal dietary conditions for hemoccult testing.

Authors:  F A Macrae; D J St John; P Caligiore; L S Taylor; J W Legge
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

5.  Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.

Authors:  F A Macrae; D J St John
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

6.  Is colonoscopy necessary in diverticular disease?

Authors:  P B Boulos; D G Karamanolis; P R Salmon; C G Clark
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

7.  Controlled trial of faecal occult blood testing in the detection of colorectal cancer.

Authors:  J D Hardcastle; P A Farrands; T W Balfour; J Chamberlain; S S Amar; M G Sheldon
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

8.  Predictive value of rectal bleeding in screening for rectal and sigmoid polyps.

Authors:  P H Chapuis; K J Goulston; O F Dent; A D Tait
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

Review 9.  Occult blood screening for colorectal carcinoma: a critical review.

Authors:  J B Simon
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

10.  Immunological detection of occult blood in bowel cancer patients.

Authors:  A Kapparis; D Frommer
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

View more
  6 in total

1.  Familial colorectal cancer: discussion paper.

Authors:  M J Underwood; V W Johnson
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

2.  Clinical study of a new fecal occult blood test using a combination assay of hemoglobin and transferrin.

Authors:  H Miyoshi; K Uchida; R Matsuse; T Amatsu; C Shimamoto; I Hirata; S Ohshiba
Journal:  Gastroenterol Jpn       Date:  1991-04

3.  Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.

Authors:  J Tibble; G Sigthorsson; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

4.  Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.

Authors:  A Cohen; J K Boeijinga; P M van Haard; R C Schoemaker; A van Vliet-Verbeek
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

5.  Urinary organ specific neoantigen. A potentially diagnostic test for colorectal cancer.

Authors:  M Tobi; C E Darmon; P Rozen; N Harpaz; A Fink; B Maliakkal; A Halline; S Mobarhan; Z Bentwich
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

Review 6.  Screening for colorectal cancer by immunochemical fecal occult blood testing.

Authors:  H Saito
Journal:  Jpn J Cancer Res       Date:  1996-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.